Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in HIMS — Hims & Hers Health, Inc.

CIK 1423053 MIAMI, FL
Back to HIMS Full portfolio

Position in HIMS

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$29,363,271
+$14,939,763 QoQ
Shares Held
846,936
+21.9% QoQ
Ownership
0.363%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#27
of 507 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Derivatives in HIMS

reported options exposure · as of Jun 30, 2026
CallValue
$210,370,626
CallShares
6,067,800
PutValue
$108,329,882
PutShares
3,124,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names. HIMS ranks #8 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
This page 		846,936 $29,363,271

All Filings in HIMS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $210,370,626 6,067,800
2026-06-30 $108,329,882 3,124,600
2026-06-30 $29,363,271 846,936
2026-03-31 $14,423,508 694,774
2026-03-31 $143,569,932 6,915,700
2026-03-31 $86,770,572 4,179,700
2025-12-31 $216,393,068 6,664,400
2025-12-31 $144,517,476 4,450,800
2025-12-31 $63,638,276 1,959,910
2025-09-30 $8,835,330 155,771
2025-09-30 $353,819,360 6,238,000
2025-09-30 $367,307,376 6,475,800
2025-06-30 $147,585,910 2,960,600
2025-06-30 $56,361,307 1,130,618
2025-06-30 $247,570,055 4,966,300
2025-03-31 $81,371,835 2,753,700
2025-03-31 $79,737,720 2,698,400
2025-03-31 $19,456,015 658,410
2024-12-31 $67,346,136 2,785,200
2024-12-31 $70,402,488 2,911,600
2024-12-31 $3,577,551 147,955
2024-09-30 $18,478,944 1,003,200
2024-09-30 $22,558,974 1,224,700
2024-09-30 $34,485,408 1,872,172
2024-06-30 $24,500,565 1,213,500
2024-06-30 $29,529,894 1,462,600
2024-06-30 $44,058,900 2,182,214
2024-03-31 $28,777,107 1,860,188
2024-03-31 $3,743,740 242,000
2024-03-31 $7,668,479 495,700
2023-12-31 $17,686,284 1,987,223
2023-12-31 $1,390,180 156,200
2023-12-31 $3,582,250 402,500
2023-09-30 $3,275,832 520,800
2023-09-30 $929,662 147,800
2023-09-30 $6,836,700 1,086,916
2023-06-30 $17,438,598 1,855,170
2023-06-30 $3,435,700 365,500
2023-06-30 $1,718,320 182,800
2023-03-31 $1,312,416 132,300
2023-03-31 $3,509,696 353,800
2023-03-31 $18,553,137 1,870,276
2022-12-31 $851,248 132,800
2022-12-31 $9,232,508 1,440,329
2022-12-31 $967,269 150,900
2022-09-30 $4,282,481 767,470
2022-09-30 $1,121,580 201,000
2022-09-30 $528,984 94,800
2022-06-30 $756,963 167,100
2022-06-30 $3,696,325 815,966